AR002239A1 - Nuevos compuestos de ariloxicicloalquenil y ariloxiiminocicloalquenilhidro xiurea y composicion farmaceutica que los contiene. - Google Patents
Nuevos compuestos de ariloxicicloalquenil y ariloxiiminocicloalquenilhidro xiurea y composicion farmaceutica que los contiene.Info
- Publication number
- AR002239A1 AR002239A1 ARP950100014A AR10001495A AR002239A1 AR 002239 A1 AR002239 A1 AR 002239A1 AR P950100014 A ARP950100014 A AR P950100014A AR 10001495 A AR10001495 A AR 10001495A AR 002239 A1 AR002239 A1 AR 002239A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- optionally substituted
- chr1
- haloalkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 101100277337 Arabidopsis thaliana DDM1 gene Proteins 0.000 abstract 3
- -1 C24 alkoxyalkoxy Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 101150113676 chr1 gene Proteins 0.000 abstract 3
- 125000001188 haloalkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000005605 benzo group Chemical group 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona un compuesto de la fórmula (I), en la que Ar es (a) fenilo, naftilo y bifenilo, cada uno opcionalmente sustituido conalquilo C14, haloalquilo C14, hidroxialquilo C14, alcoxi C14, haloalcoxi C14, alcoxialcoxi C24, alquiltio C14, hidroxi, halociano amino, alquilamino C14,dialquil (C2-3)amino, alcanoilamino C2-6, carboxi, alcoxicarbonilo C2-6 o fenilo, fenoxi, feniltio o fenilsulfinilo, opcionalmente sustituidos o (b)furilo, benzo(b)furilo, tienilo, benzo(b)tienilo, piridilo o quinolilo, cada uno opcionalmente sustituido con alquilo C14, haloalquilo C14, halo,alcoxi C14,fenilo, fenoxi y feniltio opcionalmente sustituidos, X es alquileno C1-4, alquenileno -(CHR1)m-Q1 -(CHR2)n, -O-(CHR1)j -Q2- y (CHR1)-O-N=, en donde elradical N = está unido al anillo de cicloalqueno; y en el que Q1 es O, S, SO, SO2, NR3, CH=N-O o CO, Q2 es O, S, SO, SO2 o NR3 y R1, R2 y R3 son, cada unohidrógeno o alquilo C1-4, m y n son, cada uno, un número enterode 0 a 4 y j es un entero de 1 a 4; p es el número entero 1 ó 2; Y es hidrógeno, alquiloC14, haloalquilo C14, alcoxi C14, alcoxialquilo C24, alquiltio C14, hidroxi, halo, ciano o amino; Z es hidrógeno o alquilo C14; y M es hidrógeno, un catiónfarmacéuticamente aceptable o un grupo escindible metabólicamente farmacéuticamente aceptable. Además, la invención proporciona una composiciónfarmacéutica para tratar un trastorno médico para el cual es necesario un inhibidor de la 5-lipoxigenasa en un mamífero, que comprende una cantidadterapéuticamente eficaz de un compuesto de la invención y un vehículo farmacéuticamene aceptable. Preferiblemente, el trastorno médico es unaenfermedad inflamatoria, una alergia o enfermedades cardiovasculares.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9401897 | 1994-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002239A1 true AR002239A1 (es) | 1998-03-11 |
Family
ID=14098792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100014A AR002239A1 (es) | 1994-11-10 | 1995-11-01 | Nuevos compuestos de ariloxicicloalquenil y ariloxiiminocicloalquenilhidro xiurea y composicion farmaceutica que los contiene. |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5798383A (es) |
| EP (1) | EP0790981B1 (es) |
| KR (1) | KR0182321B1 (es) |
| AR (1) | AR002239A1 (es) |
| AT (1) | ATE184272T1 (es) |
| AU (1) | AU690354B2 (es) |
| BR (1) | BR9505130A (es) |
| CA (1) | CA2205033C (es) |
| CO (1) | CO4520227A1 (es) |
| CZ (1) | CZ282832B6 (es) |
| DE (1) | DE69512080T2 (es) |
| ES (1) | ES2135066T3 (es) |
| FI (1) | FI113643B (es) |
| GR (1) | GR3031378T3 (es) |
| IL (1) | IL115853A (es) |
| MX (1) | MX9703485A (es) |
| MY (1) | MY112595A (es) |
| NO (1) | NO305362B1 (es) |
| NZ (1) | NZ280434A (es) |
| PE (1) | PE49596A1 (es) |
| PL (1) | PL179023B1 (es) |
| RU (1) | RU2119479C1 (es) |
| SG (1) | SG44332A1 (es) |
| TR (1) | TR199501413A2 (es) |
| TW (1) | TW363960B (es) |
| WO (1) | WO1996015106A1 (es) |
| ZA (1) | ZA959512B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
| WO2018143359A1 (ja) * | 2017-02-03 | 2018-08-09 | 日産化学工業株式会社 | ウレア結合を有する構造単位を有するポリマーを含むレジスト下層膜形成組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物 |
| US5326883A (en) * | 1992-12-18 | 1994-07-05 | Abbott Laboratories | Oxime ether derivatives having lipoxygenase inhibitory activity |
| DE69411003T2 (de) * | 1993-04-07 | 1998-10-08 | Pfizer | Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren |
| TW418089B (en) * | 1993-08-19 | 2001-01-11 | Pfizer | Pharmaceutical composition comprising phenoxyphenyl cyclopentenyl hydroxyureas (the dextrorotary isomers) |
-
1995
- 1995-05-26 EP EP95918112A patent/EP0790981B1/en not_active Expired - Lifetime
- 1995-05-26 WO PCT/IB1995/000399 patent/WO1996015106A1/en active IP Right Grant
- 1995-05-26 DE DE69512080T patent/DE69512080T2/de not_active Expired - Fee Related
- 1995-05-26 AT AT95918112T patent/ATE184272T1/de not_active IP Right Cessation
- 1995-05-26 ES ES95918112T patent/ES2135066T3/es not_active Expired - Lifetime
- 1995-05-26 CA CA002205033A patent/CA2205033C/en not_active Expired - Fee Related
- 1995-05-26 US US08/836,452 patent/US5798383A/en not_active Expired - Fee Related
- 1995-05-26 MX MX9703485A patent/MX9703485A/es unknown
- 1995-10-30 MY MYPI95003267A patent/MY112595A/en unknown
- 1995-11-01 AR ARP950100014A patent/AR002239A1/es unknown
- 1995-11-02 IL IL11585395A patent/IL115853A/xx active IP Right Grant
- 1995-11-03 SG SG1995001721A patent/SG44332A1/en unknown
- 1995-11-07 PE PE1995284002A patent/PE49596A1/es not_active Application Discontinuation
- 1995-11-08 TW TW084111851A patent/TW363960B/zh active
- 1995-11-09 NO NO954530A patent/NO305362B1/no not_active IP Right Cessation
- 1995-11-09 PL PL95311325A patent/PL179023B1/pl unknown
- 1995-11-09 ZA ZA959512A patent/ZA959512B/xx unknown
- 1995-11-09 CZ CZ952942A patent/CZ282832B6/cs not_active IP Right Cessation
- 1995-11-09 RU RU95119414/04A patent/RU2119479C1/ru not_active IP Right Cessation
- 1995-11-09 BR BR9505130A patent/BR9505130A/pt not_active IP Right Cessation
- 1995-11-09 AU AU37764/95A patent/AU690354B2/en not_active Ceased
- 1995-11-09 NZ NZ280434A patent/NZ280434A/en unknown
- 1995-11-09 KR KR1019950040425A patent/KR0182321B1/ko not_active IP Right Cessation
- 1995-11-10 CO CO95053260A patent/CO4520227A1/es unknown
- 1995-11-10 TR TR95/01413A patent/TR199501413A2/xx unknown
-
1997
- 1997-05-09 FI FI971994A patent/FI113643B/fi not_active IP Right Cessation
-
1999
- 1999-09-29 GR GR990402472T patent/GR3031378T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25142A1 (es) | Antagonistas del receptor ccr-3 | |
| MX9101280A (es) | Compuestos inhibidores de la trombina y composicion farmaceutica que los contiene | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| CO5640124A2 (es) | Combinacion de un antagonista de mglur2 y un inhibidor de ache para el tratamiento de trastornos neurologicos agudos y/o cronicos | |
| AR034858A1 (es) | Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento | |
| ATE309999T1 (de) | Blutplättchen-adp-rezeptor-inhibitoren | |
| CO5590894A2 (es) | Derivados de a-(n-sulfonamido)acetamida como inhibidores del peptido b-amiloideo | |
| AR011093A1 (es) | Compuestos derivados de sulfonil urea, composicion farmaceutica que los contiene y procedimiento para su uso. | |
| AR061101A1 (es) | Compuesto de fenil-triazolil- metoxi- arilo, su uso para la manufactura de un medicamento y composicion farmaceutica que lo comprende | |
| IL163625A0 (en) | Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same | |
| AR006833A1 (es) | Compuestos de beta lactama monociclicos, composicion farmaceutica que los contiene, uso de dichos compuestos para preparar medicamentos, procedimientopara preparar dichos compuestos, compuestos intermediarios y procedimientos para preparar dichos compuestos intermediarios. | |
| AR048573A1 (es) | Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima | |
| AR046874A1 (es) | Nuevos metodos | |
| AR053657A1 (es) | Inhibidores duales antitromboticos que comprenden un residuo de biotina | |
| AR009363A1 (es) | Compuestos 3-mercaptoacetilamino-1,5-sustituido--oxo-azepan utiles como inhibidores de metaloproteinasas de la matriz, composicion farmaceutica y usos para la fabricacion de medicamentos para el tratamiento de enfermedades que responden a la inhibicion de metaloproteinasas de la matriz | |
| AR002239A1 (es) | Nuevos compuestos de ariloxicicloalquenil y ariloxiiminocicloalquenilhidro xiurea y composicion farmaceutica que los contiene. | |
| EA200000948A1 (ru) | Новые полициклические азаиндолы, способ их получения и фармацевтические композиции, содержащие их | |
| AR018632A1 (es) | Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion. | |
| AR041720A1 (es) | Derivados de n- benzodioxolilo, n- benzodioxanilo y n- benzodioxepinilarilcarboxamida que pueden usarse para el tratamiento de dislipidemia, y composiciones farmaceuticas que los contienen | |
| ES2183500T3 (es) | Nuevos compuestos y composiciones farmaceuticas que los contienen. | |
| BR0012502A (pt) | Inibidores da expressão do gene para interleucina 5 | |
| AR126756A1 (es) | Compuestos heterocíclicos y métodos de uso | |
| AR051319A1 (es) | Administracion pulmonar de un compuesto antitrombotico | |
| AR046233A1 (es) | Derivados de piperidinillactamas, procedimiento para prepararlos y composicion farmaceutica. | |
| AR103818A2 (es) | Derivados de pirrolopirimidina inhibidores de mieloperoxidasa (mpo) |